Product
Fostemsavir
3 clinical trials
3 indications
Indication
HIV InfectionsIndication
HIV-1 infectionClinical trial
Fostemsavir Compassionate Use Named Patient Program for the Treatment of Human Immunodeficiency Virus 1 (HIV-1)Status:
Clinical trial
A Multicenter, Open-label, Single-arm Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of Fostemsavir in Combination With Optimized Background Therapy (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their Current Combination Antiretroviral Therapy (cART) and Have Dual- or Triple-class Antiretroviral (ARV) ResistanceStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER StudyStatus: Recruiting, Estimated PCD: 2024-07-31